Paper

Rizello F, Gionchetti P, D’Arienzo A et al. Oral beclomethasone dipropionate in the treatment of active ulcerative colitis: a double blind placebo controlled study. Aliment Pharmacol Ther. 2002;16:1109-1116.

Marr KA, Carter RA, Boeckh M et al. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood. 2002;100:4358-4366.

Mettler, FA, Jr. and GL Voelz, Major radiation exposure--what to expect and how to respond. N Engl J Med, 2002. 346(20): 1554-61.

Janeway CA, Jr., Medzhitov R. Innate immune recognition. Annu Rev Immunol. 2002;20,197-216.

Matzinger, P. The Danger Model : A renewed sense of self. Science. 2002; 296(5566), 301-305

Matzinger P. 2002a. The danger model: a renewed sense of self. Science 296: 301-5

Janeway CA, Jr., Medzhitov R. 2002. Innate immune recognition. Annu Rev Immunol 20: 197-216

Geetha T and Wooten MW. 2002. Structure and functional properties of the ubiquitin binding protein p62. FEBS Letters 512: 19-24

Campieri M, Cottone M, Miglio F et al. Beclomethasone dipropionate enemas versus prednisolone sodium phosphate enemas in the treatment of distal ulcerative colitis. Aliment. Pharmacol. Ther. 1998;l12:361-366.

Campieri M, Cottone M, Miglio F et al. Beclomethasone dipropionate enemas versus prednisolone sodium phosphate enemas in the treatment of distal ulcerative colitis. Aliment Pharmacol Ther. 1998;12: 361-366.